About Initia Pharma
Initia Pharma is a Healthcare company based in India founded in 2002. It operates as a pharmaceutical company specializing in pharmachem solutions. It operates on a B2B model. Its Indian entity Initia Pharmachem Private Limited reported revenue of ₹4.8 Lakh. Its focus areas include Pharmaceuticals, Pharmachem and Chemical Manufacturing.
Company details
Initia Pharma operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, pharmachem, and chemical manufacturing. Operates as a pharmaceutical company specializing in pharmachem solutions. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
- Headquarters India
- SectorsHealthcare
- Website initiapharma.com
- Legal Name Initia Pharmachem Private Limited
- Date of Incorporation 22 Mar, 2001
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹4.8 Lakh
FY 2025 · -12% YoY
- Net Profit₹26,379
FY 2025 · 6% margin
- EBITDA₹57,685
FY 2025 · 12% margin
Associated legal entities of Initia Pharma
Initia Pharma operates through Initia Pharmachem Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Initia Pharmachem Private Limited CIN U24117MH2001PTC131344 | Active | 22 Mar 2001 | Mumbai, Maharashtra | ₹0.0 Cr | – | 2 | View details |
Board of directors of Initia Pharmachem Private Limited (Initia Pharma)
Initia Pharmachem Private Limited is the primary company behind Initia Pharma. The board of Initia Pharmachem Private Limited currently have 2 directors; the longest-serving is Mangala Eknath Kalyanpur, appointed in 2001. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Mangala Eknath Kalyanpur DIN 02452777 | Director | 22 Mar 2001 | 25 yrs 6 mo | Initia Pharmachem Private Limited |
| Eknath Umesh Kalyanpur DIN 00672993 | Director | 01 Oct 2011 | 15 yrs | Initia Pharmachem Private Limited |
Financials of Initia Pharma
Figures of Initia Pharmachem Private Limited, the primary company behind Initia Pharma, for FY 2025. Revenue was ₹4.8 Lakh (-12% year on year). Net profit was ₹26,379 (6% margin). EBITDA was ₹57,685 (12% margin). Revenue has grown at a compounded annual rate of -8% over three years and +16% over five years.
- ₹4.8 LakhRevenue · FY 2025 · -12% YoY
- ₹26,379Net profit · 6% margin
- ₹57,685EBITDA · 12% margin
- ₹1 LakhPaid-up capital
- -8%Revenue CAGR, 3 years
- +16%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Initia Pharmachem Private Limited are on its company page.
Detailed financial statements for Initia Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Initia Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Initia Pharma
Initia Pharma was founded in 2002.
Initia Pharma is headquartered in India.
The primary company behind Initia Pharma, Initia Pharmachem Private Limited, reported revenue of ₹4.8 Lakh for FY 2025, down 12% year on year.
Initia Pharma operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, pharmachem, and chemical manufacturing. Operates as a pharmaceutical company specializing in pharmachem solutions. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Initia Pharma operates through Initia Pharmachem Private Limited.
The legal entities of Initia Pharma currently have 2 directors, including Eknath Umesh Kalyanpur, Mangala Eknath Kalyanpur.